Synaptys Neuroscience: preventing Alzheimer’s disease with combination therapy
… positive results in vitro in a study carried out in 2022: according to Sébastien Lasnier, “42 per cent of … candidate, the start-up went through four stages. The first was to identify the right molecules, which took two years. … they had to identify the correct receptor and, once this was done, the precise target or the right site to target on …
Published on: